Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NR2F2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SNX10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP4K5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC646214 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TMEM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THOC7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FREM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PBRM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MDFIC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KPNA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PGM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRFIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF146 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF3J - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DMXL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD3EAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on